Published in Dis Model Mech on May 01, 2015
In Pursuit of Authenticity: Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Clinical Applications. Stem Cells Transl Med (2016) 0.81
Ultrathin Polyimide Membrane as Cell Carrier for Subretinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigment Epithelium. PLoS One (2015) 0.79
The Endocannabinoid System in the Retina: From Physiology to Practical and Therapeutic Applications. Neural Plast (2016) 0.78
In Vitro Cell Models for Ophthalmic Drug Development Applications. Biores Open Access (2016) 0.77
Norbixin Protects Retinal Pigmented Epithelium Cells and Photoreceptors against A2E-Mediated Phototoxicity In Vitro and In Vivo. PLoS One (2016) 0.75
From bench to patient: model systems in drug discovery. Dis Model Mech (2015) 0.75
A basis for comparison: sensitive authentication of stem cell derived RPE using physiological responses of intact RPE monolayers. Stem Cell Transl Investig (2017) 0.75
Long-Term Efficacy of GMP Grade Xeno-Free hESC-Derived RPE Cells Following Transplantation. Transl Vis Sci Technol (2017) 0.75
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 120.51
Embryonic stem cell lines derived from human blastocysts. Science (1998) 65.53
A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A (2005) 13.44
Reference Maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell (2011) 8.21
Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet (2012) 7.70
The third dimension bridges the gap between cell culture and live tissue. Nat Rev Mol Cell Biol (2007) 7.38
Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med (2007) 6.47
ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp Eye Res (1996) 5.97
Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature (2009) 5.37
Complement activation and inflammatory processes in Drusen formation and age related macular degeneration. Exp Eye Res (2001) 4.38
Self-formation of optic cups and storable stratified neural retina from human ESCs. Cell Stem Cell (2012) 3.85
Endogenous VEGF is required for visual function: evidence for a survival role on müller cells and photoreceptors. PLoS One (2008) 3.46
The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog Retin Eye Res (2009) 3.40
Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells. Nature (2012) 3.09
Directed differentiation of human embryonic stem cells into functional retinal pigment epithelium cells. Cell Stem Cell (2009) 3.09
Generation of retinal cells from mouse and human induced pluripotent stem cells. Neurosci Lett (2009) 2.75
Confluent monolayers of cultured human fetal retinal pigment epithelium exhibit morphology and physiology of native tissue. Invest Ophthalmol Vis Sci (2006) 2.74
Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells. Stem Cells (2009) 2.70
Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration. Stem Cells (2009) 2.56
Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat. PLoS One (2009) 2.54
Stem cells: The dark side of induced pluripotency. Nature (2011) 2.49
Adult human RPE can be activated into a multipotent stem cell that produces mesenchymal derivatives. Cell Stem Cell (2012) 2.32
Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics. Cloning Stem Cells (2004) 2.32
Optic vesicle-like structures derived from human pluripotent stem cells facilitate a customized approach to retinal disease treatment. Stem Cells (2011) 2.26
Human embryonic stem cell-derived cells rescue visual function in dystrophic RCS rats. Cloning Stem Cells (2006) 2.23
Immunology of age-related macular degeneration. Nat Rev Immunol (2013) 2.14
Characterization of human induced pluripotent stem cell-derived retinal pigment epithelium cell sheets aiming for clinical application. Stem Cell Reports (2014) 2.03
A protocol for the culture and differentiation of highly polarized human retinal pigment epithelial cells. Nat Protoc (2009) 1.91
Risk factors for age-related maculopathy: the Visual Impairment Project. Arch Ophthalmol (2001) 1.88
Modeling retinal degeneration using patient-specific induced pluripotent stem cells. PLoS One (2011) 1.78
The dynamic nature of Bruch's membrane. Prog Retin Eye Res (2009) 1.71
Generation of three-dimensional retinal tissue with functional photoreceptors from human iPSCs. Nat Commun (2014) 1.68
HLA-haplotype banking and iPS cells. Nat Biotechnol (2008) 1.61
iPS cell modeling of Best disease: insights into the pathophysiology of an inherited macular degeneration. Hum Mol Genet (2012) 1.59
Human retinal pigment epithelium cells as functional models for the RPE in vivo. Invest Ophthalmol Vis Sci (2011) 1.55
Development of human embryonic stem cell therapies for age-related macular degeneration. Trends Neurosci (2013) 1.51
The promise of human embryonic stem cells in aging-associated diseases. Aging (Albany NY) (2011) 1.49
Animal models of age related macular degeneration. Mol Aspects Med (2012) 1.39
Mouse embryonic stem cell culture for generation of three-dimensional retinal and cortical tissues. Nat Protoc (2011) 1.38
Cell culture model that mimics drusen formation and triggers complement activation associated with age-related macular degeneration. Proc Natl Acad Sci U S A (2011) 1.30
Subretinal implantation of retinal pigment epithelial cells derived from human embryonic stem cells: improved survival when implanted as a monolayer. Invest Ophthalmol Vis Sci (2013) 1.30
Mechanisms of skeletal muscle aging: insights from Drosophila and mammalian models. Dis Model Mech (2013) 1.28
Differentiation of human pluripotent stem cells to retinal pigmented epithelium in defined conditions using purified extracellular matrix proteins. J Tissue Eng Regen Med (2012) 1.27
C2 and CFB genes in age-related maculopathy and joint action with CFH and LOC387715 genes. PLoS One (2008) 1.22
Generation of retinal pigment epithelial cells from small molecules and OCT4 reprogrammed human induced pluripotent stem cells. Stem Cells Transl Med (2012) 1.11
Human RPE stem cells grown into polarized RPE monolayers on a polyester matrix are maintained after grafting into rabbit subretinal space. Stem Cell Reports (2014) 1.11
Cell culture models of the ocular barriers. Eur J Pharm Biopharm (2005) 1.11
A novel approach for subretinal implantation of ultrathin substrates containing stem cell-derived retinal pigment epithelium monolayer. Ophthalmic Res (2012) 1.10
Switching cell fate: the remarkable rise of induced pluripotent stem cells and lineage reprogramming technologies. Trends Biotechnol (2010) 1.10
A simple and scalable process for the differentiation of retinal pigment epithelium from human pluripotent stem cells. Stem Cells Transl Med (2013) 1.09
Animals as models of age-related macular degeneration: an imperfect measure of the truth. Vet Pathol (2010) 1.08
Validation of genome-wide association study (GWAS)-identified disease risk alleles with patient-specific stem cell lines. Hum Mol Genet (2014) 1.06
Developing cellular therapies for retinal degenerative diseases. Invest Ophthalmol Vis Sci (2014) 1.03
Mesh-supported submicron parylene-C membranes for culturing retinal pigment epithelial cells. Biomed Microdevices (2012) 1.00
Modeling human retinal development with patient-specific induced pluripotent stem cells reveals multiple roles for visual system homeobox 2. Stem Cells (2014) 0.99
Phenotypic screening with human iPS cell-derived cardiomyocytes: HTS-compatible assays for interrogating cardiac hypertrophy. J Biomol Screen (2013) 0.96
Chronic oxidative stress upregulates Drusen-related protein expression in adult human RPE stem cell-derived RPE cells: a novel culture model for dry AMD. Aging (Albany NY) (2013) 0.91
Structure and barrier properties of human embryonic stem cell-derived retinal pigment epithelial cells are affected by extracellular matrix protein coating. Tissue Eng Part A (2014) 0.90
Stem cells as tools in regenerative therapy for retinal degeneration. Arch Ophthalmol (2009) 0.89
The cultivation of human retinal pigment epithelial cells on Bombyx mori silk fibroin. Biomaterials (2012) 0.89
Differentiation of pluripotent stem cells into retinal pigmented epithelium. Dev Ophthalmol (2014) 0.87
Psychosocial effects of age-related macular degeneration. Int Psychogeriatr (2006) 0.87
Cultured primary human fetal retinal pigment epithelium (hfRPE) as a model for evaluating RPE metabolism. Exp Eye Res (2014) 0.86
Conditional knockdown of DNA methyltransferase 1 reveals a key role of retinal pigment epithelium integrity in photoreceptor outer segment morphogenesis. Development (2013) 0.86
Bisretinoid-mediated complement activation on retinal pigment epithelial cells is dependent on complement factor H haplotype. J Biol Chem (2014) 0.84
Enhancement of retinal pigment epithelial culture characteristics and subretinal space tolerance of scaffolds with 200 nm fiber topography. Biomaterials (2014) 0.83
Porous poly(ε-caprolactone) scaffolds for retinal pigment epithelium transplantation. Invest Ophthalmol Vis Sci (2014) 0.83
Modeling retinal degenerative diseases with human iPS-derived cells: current status and future implications. Expert Rev Ophthalmol (2013) 0.83
Expression and role of VEGF--a in the ciliary body. Invest Ophthalmol Vis Sci (2012) 0.83
Modeling retinal dystrophies using patient-derived induced pluripotent stem cells. Adv Exp Med Biol (2014) 0.83
Isolation and properties of an in vitro human outer blood-retinal barrier model. Methods Mol Biol (2011) 0.83
Novel compstatin family peptides inhibit complement activation by drusen-like deposits in human retinal pigmented epithelial cell cultures. Exp Eye Res (2013) 0.83
Complement system in pathogenesis of AMD: dual player in degeneration and protection of retinal tissue. J Immunol Res (2014) 0.81
A targeted inhibitor of the complement alternative pathway reduces RPE injury and angiogenesis in models of age-related macular degeneration. Adv Exp Med Biol (2010) 0.80
Utilizing stem cell-derived RPE cells as a therapeutic intervention for age-related macular degeneration. Adv Exp Med Biol (2014) 0.79
Modulation of Sub-RPE deposits in vitro: a potential model for age-related macular degeneration. Invest Ophthalmol Vis Sci (2004) 0.79
Stem cell-based treatment in geographic atrophy: promises and pitfalls. Acta Ophthalmol (2013) 0.79
Untapping the potential of human retinal pigmented epithelial cells. Cell Stem Cell (2012) 0.77
Modulation of growth in retina-derived cells by extracellular matrices. Invest Ophthalmol Vis Sci (1990) 0.77
Next-generation AMD drugs to wed blockbusters. Nat Biotechnol (2014) 0.77
Stem cell therapy clears first hurdle in AMD. Nat Biotechnol (2014) 0.76
Cell culture models and nanobiotechnology--contemporary topics in advanced drug delivery research. Eur J Pharm Biopharm (2005) 0.76
Disease-in-a-dish: the contribution of patient-specific induced pluripotent stem cell technology to regenerative rehabilitation. Am J Phys Med Rehabil (2014) 0.76
Eyes on 3D-current 3D biomimetic disease concept models and potential applications in age-related macular degeneration. Adv Healthc Mater (2013) 0.76